» Articles » PMID: 39716257

Decoding Burn Trauma: Biomarkers for Early Diagnosis of Burn-induced Pathologies

Overview
Journal Biomark Res
Publisher Biomed Central
Date 2024 Dec 24
PMID 39716257
Authors
Affiliations
Soon will be listed here.
Abstract

Burn injuries represent a significant global challenge due to their multifaceted nature, characterized by a complex cascade of metabolic and immune dysfunction that can result in severe complications. If not identified and managed promptly, these complications can escalate, often leading to fatal outcomes. This underscores the critical importance of timely and precise diagnosis. Fortunately, biomarkers for burn-induced pathologies and outcomes have emerged as powerful diagnostic and prognostic tools. These biomarkers enable early diagnosis and intervention, facilitate risk assessment, support patient-specific treatment, monitoring of disease progression, and therapeutic efficacy, ultimately contributing to improved patient outcomes. However, while previous studies have provided valuable biomarkers for the detection of burn-induced pathologies, many of these were constrained by the techniques and sample sizes available at the time, which can limit the generalizability of the findings. This review highlights numerous biomarkers studied in the literature to date, underscoring the need to replicate these findings in more diverse and representative populations. It also emphasizes the importance of advancing research efforts to develop more efficient, accurate, and cost-effective approaches for integrating biomarkers into clinical practice.

References
1.
Mulder P, Vlig M, Boekema B, Stoop M, Pijpe A, van Zuijlen P . Persistent Systemic Inflammation in Patients With Severe Burn Injury Is Accompanied by Influx of Immature Neutrophils and Shifts in T Cell Subsets and Cytokine Profiles. Front Immunol. 2021; 11:621222. PMC: 7879574. DOI: 10.3389/fimmu.2020.621222. View

2.
Matsuura H, Osuka A, Hirose T, Ogura H, Ueyama M, Shimazu T . C1 Esterase Inhibitor Activity Is Reduced in the Acute Phase Following Burn Injury: A Prospective Observational Study. J Burn Care Res. 2019; 40(6):893-899. DOI: 10.1093/jbcr/irz109. View

3.
Segura C, Golovko G, Obias I, Shah S, El Ayadi A, Wolf S . Elevated Cardiac Troponin I Level Associated to Cardiac Dysfunction in Burned Patients. J Burn Care Res. 2024; 45(5):1139-1147. PMC: 11379147. DOI: 10.1093/jbcr/irae086. View

4.
Csontos C, Foldi V, Palinkas L, Bogar L, Roth E, Weber G . Time course of pro- and anti-inflammatory cytokine levels in patients with burns--prognostic value of interleukin-10. Burns. 2010; 36(4):483-94. DOI: 10.1016/j.burns.2009.10.009. View

5.
Zhang T, Ba T, Li F, Chen Q, Chen Z, Zhou B . Coagulation dysfunction of severe burn patients: A potential cause of death. Burns. 2022; 49(3):678-687. DOI: 10.1016/j.burns.2022.05.003. View